Lenalidomide Plus Decitabine Treatment in a Myelodysplastic Syndrome Patient With Deletion 5q and Excess Blasts.

Serin, Istemi; Eren, Rafet; Dogu, Mehmet Hilmi

Serin, Istemi; Eren, Rafet; Dogu, Mehmet Hilmi.

Afiliación

Serin I; Department of Hematology, University of Health Science, Istanbul Training and Research Hospital, Istanbul, Turkey.
Eren R; Department of Hematology, University of Health Science, Okmeydani Training and Research Hospital, Istanbul, Turkey.
Dogu MH; Department of Hematology, University of Health Science, Istanbul Training and Research Hospital, Istanbul, Turkey.

J Hematol ; 9(1-2): 33-36, 2020 Apr.

Article en En | MEDLINE | ID: mdl-32362984

Palabras clave

Decitabine; Del(5q); Lenalidomide; Myelodysplastic syndrome

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Hematol Año: 2020 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Canadá

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google